# Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation

> **NCT02002988** · PHASE1 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 30 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **PROCEDURE:** endomyocardial BT injection

## Key facts

- **NCT ID:** NCT02002988
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002988, "Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02002988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*